Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_assertion description "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_assertion evidence source_evidence_literature NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_assertion SIO_000772 11244573 NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_assertion wasDerivedFrom befree-20140225 NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_assertion wasGeneratedBy ECO_0000203 NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP619322.RAy9nw_X8h8dI0KXV5hGFm63TulXh0KB8WTjui-88ORHA130_provenance.